ISPOR - Cost Minimization Analysis of Bevacizumab Versus Cetuximab and Panitumumab in the Management of Colorectal Cancer from Patient Perspective in Egypt

Full Text

Cost Minimization Analysis of Bevacizumab Versus Cetuximab and Panitumumab in the Management of Colorectal Cancer from Patient Perspective in Egypt

Abstract

Authors

MF Ragab RA Assal MM Abdelrahman G Elsisi

Back to Volume 19, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now